Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma

The importance of compliance with National Comprehensive Cancer Network (NCCN) guidelines for preventing varicella-zoster virus reactivation (VZVr) in multiple myeloma (MM) in a clinical setting has not been well investigated. We retrospectively studied the clinical characteristics and outcomes of 1...

Full description

Saved in:

Bibliographic Details
Published in:	In vivo (Athens) Vol. 35; no. 6; pp. 3289 - 3296
Main Authors:	Ohashi, Yasukata, Yatabe, Megumi, Niijima, Daisuke, Imamura, Arina, Nagayama, Yoshiyuki, Otsuka, Kentaro, Yachi, Yutaka, Ueno, Hironori, Yano, Takahiro, Mori, Nobuaki, Higai, Koji, Yokoyama, Akihiro
Format:	Journal Article
Language:	English
Published:	Greece International Institute of Anticancer Research 01-11-2021
Subjects:	Acyclovir - therapeutic use Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Herpes Zoster - drug therapy Herpes Zoster - prevention & control Herpesvirus 3, Human Humans Multiple Myeloma - drug therapy Retrospective Studies Virus Activation NCCN guidelines proteasome inhibitors Varicella-zoster virus reactivation multiple myeloma compliance
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The importance of compliance with National Comprehensive Cancer Network (NCCN) guidelines for preventing varicella-zoster virus reactivation (VZVr) in multiple myeloma (MM) in a clinical setting has not been well investigated. We retrospectively studied the clinical characteristics and outcomes of 118 patients with MM treated with proteasome inhibitors. Thirty-nine episodes of VZVr were observed in 37 patients (VZVr group). The proportion of prophylactic antiviral prescriptions and compliance with antiviral prophylaxis based on the NCCN Clinical Practice guidelines was 76% and 30% in the VZVr group, and 88% and 74% in the non-VZVr group, respectively. Multivariate analysis showed that compliance with the NCCN guidelines was the only independent risk factor for VZVr (p=0.0017). It is important that prophylactic antivirals are prescribed for an appropriate duration of time to prevent the reactivation of VZV in compliance with existing guidelines.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0258-851X 1791-7549
DOI:	10.21873/invivo.12624